MediShield Life and the cost of cancer treatment

The affordability of treatment is an urgent issue given the rising number of cases. A balance needs to be struck, taking into account the interests of patients, the national health budget and the stakeholders in the healthcare ecosystem.

Through the years, Singapore’s healthcare service has built a strong reputation of high standards, efficiency, reliability and being at the forefront of research and innovation, says the writer. PHOTO: ST FILE
New: Gift this subscriber-only story to your friends and family

During the public consultation phase of the review of MediShield Life last year, the Singapore Society of Oncology (SSO), a professional medical organisation consisting of doctors who treat and manage cancer patients, shared its views.

Among the issues raised was the high prices of new cancer drugs and the affordability of treatment. There was a suggestion to augment efforts in negotiating better prices with pharmaceutical companies for the financial sustainability of our national healthcare system.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.